会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • Cis-Bicyclo[4.3.0]non-2-ene derivatives
    • Cis-Bicyclo¬4.3.O非2-en-Derivate
    • EP0431571A2
    • 1991-06-12
    • EP90123253.8
    • 1990-12-04
    • SAGAMI CHEMICAL RESEARCH CENTERTOA EIYO LTD.
    • Shibasaki, MasakatsuTakahasi, AtsuoAoki, TuyosiSato, HiroyasuYamada, Shin-ichiKudo, MichikoYamaguchi, TakajiKogi, KentaroNarita, Sen-ichi
    • C07C405/00C07C69/738C07C69/712A61K31/557
    • C07C69/738C07C59/46C07C59/62C07C69/712C07C69/732C07C405/0083Y02P20/55
    • A cis-bicyclo[4.3.0]non-2-ene derivative of the formula:

      wherein R is a hydrogen atom, or a protecting group for a hydroxyl group, R¹ is a hydrogen atom, a

              C₁-C₁₂

      straight or branched chain alkyl group, a substituted or unsubstituted phenyl group, a

              C₆-C₁₂

      aralkyl group containing a condensed aromatic ring or an aromatic hetero ring, or 1 equivalent of a cation, A is

              -CH=CH-



              CH₂-,

      or

              -CH₂-CH₂-O- ,

      R² is a

              C₃-C₁₀

      straight or branched chain alkyl group, a

              C₁-C₃

      alkyl group substituted by an aryloxy group which may be substituted, a

              C₃-C₁₂

      straight or branched chain alkenyl group, a

              C₃-C₈

      straight or branched chain alkynyl group, or a

              C₁-C₃

      alkyl group substituted by a phenyl or phenoxy group which may be substituted, by a

              C₁-C₆

      alkoxy group or by a

              C₅-C₈

      cycloalkyl group, R³ is a hydrogen atom, a methyl group, or a vinyl group, and X is a halogen atom.
    • 下式的顺式 - 双环[4.3.0]壬-2-烯衍生物:其中R是氢原子或羟基保护基,其中R 1是氢原子,C1- C12直链或支链烷基,取代或未取代的苯基,含有稠合芳环或芳族杂环的C 6 -C 12芳烷基或1当量阳离子,A为-CH = CH-CH 2 - 或 -CH 2 -CH 2 -O - ,R 2是C 3 -C 10直链或支链烷基,被可被取代的芳氧基取代的C1-C3烷基,C3-C12直链或支链烯基 C 3 -C 8直链或支链炔基或被可被取代的苯基或苯氧基取代的C 1 -C 3烷基,被C 1 -C 6烷氧基或C 5 -C 8环烷基取代,R 3 >是氢原子,甲基或乙烯基,X是卤素原子。
    • 2. 发明公开
    • Cis-Bicyclo[4.3.0]non-2-ene derivatives
    • 顺式 - 双环[4.3.0]壬-2-烯衍生物
    • EP0431571A3
    • 1992-01-02
    • EP90123253.8
    • 1990-12-04
    • SAGAMI CHEMICAL RESEARCH CENTERTOA EIYO LTD.
    • Shibasaki, MasakatsuTakahasi, AtsuoAoki, TuyosiSato, HiroyasuYamada, Shin-ichiKudo, MichikoYamaguchi, TakajiKogi, KentaroNarita, Sen-ichi
    • C07C405/00C07C69/738C07C69/712A61K31/557
    • C07C69/738C07C59/46C07C59/62C07C69/712C07C69/732C07C405/0083Y02P20/55
    • A cis-bicyclo[4.3.0]non-2-ene derivative of the formula:

      wherein R is a hydrogen atom, or a protecting group for a hydroxyl group, R¹ is a hydrogen atom, a
              C₁-C₁₂
      straight or branched chain alkyl group, a substituted or unsubstituted phenyl group, a
              C₆-C₁₂
      aralkyl group containing a condensed aromatic ring or an aromatic hetero ring, or 1 equivalent of a cation, A is
              -CH=CH-
              CH₂-,
      or
              -CH₂-CH₂-O- ,
      R² is a
              C₃-C₁₀
      straight or branched chain alkyl group, a
              C₁-C₃
      alkyl group substituted by an aryloxy group which may be substituted, a
              C₃-C₁₂
      straight or branched chain alkenyl group, a
              C₃-C₈
      straight or branched chain alkynyl group, or a
              C₁-C₃
      alkyl group substituted by a phenyl or phenoxy group which may be substituted, by a
              C₁-C₆
      alkoxy group or by a
              C₅-C₈
      cycloalkyl group, R³ is a hydrogen atom, a methyl group, or a vinyl group, and X is a halogen atom.
    • 下式的顺式 - 二环[4.3.0]壬-2-烯衍生物:其中R是氢原子或羟基保护基,R 1是氢原子,C 1 -C 12直链或支链烷基 取代或未取代的苯基,含有稠合芳环或芳香杂环的C 6 -C 12芳烷基,或1当量的阳离子,A是-CH = CH-CH 2 - 或-CH 2 -CH 2 -O - ,R 2为C 3 -C 10直链或支链烷基,被可被取代的芳氧基取代的C 1 -C 3烷基,C 3 -C 12直链或支链链烯基,C 3 -C 8直链或支链 炔基或被苯基或苯氧基取代的C 1 -C 3烷基,它们可以是取代的 通过C 1 -C 6烷氧基或C 5 -C 8环烷基取代,R 3是氢原子,甲基或乙烯基,X是卤素原子。
    • 7. 发明公开
    • Pharmaceuticals containing prostaglandin I2
    • Arzneimittel死亡前列腺素I2窒息。
    • EP0171992A2
    • 1986-02-19
    • EP85305611.7
    • 1985-08-07
    • MITSUBISHI KASEI CORPORATIONSAGAMI CHEMICAL RESEARCH CENTER
    • Ishibashi, AkiraHorii, DaijiroKanayama, ToshijiIseki, KatsuhikoShinoda, MasakiIshiyama, ChiyokoHayashi, YosioShibasaki, MasakatsuSodeoka, MikikoOgawa, YujiMase, Toshiaki
    • A61K31/557
    • C07C405/0083A61K31/557
    • Disclosed is a pharmaceutical having circulation ameliorating effect and antiulcer effect containing a prostaglandin I 2 analogue represented by the formula shown below or a non-toxic salt of its salt or a cyclodextrin inclusion compound thereof as the effective ingredient:
      wherein R' represents a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a cycloalkyl group having 4 to 7 carbon atoms or a phenyl group,
      A represents a pentyl group, a cyclopentyl group, a cyclohexyl group, a 1-methyl-3-hexynyl group, a 2-methyl-3-hexynyl group, a 1-methythexyl group, a 2-phenethyl group, a 1,1-dimethylpentyl group, a 2-methylpentyl group, a 1-cyclohexylethyl group, a 2-methylhexyl group, a 1-methyl-3-pentynyl group or a 2,6-dimethyl-5-heptenyl group, the double bond between the carbon atoms at 4- and 5-positions is E or Z or a mixture thereof, the asymmetric center in the substituent represented by A is R-configuration or S-configuration or a mixture thereof.
      The pharmaceuticals containing, as an active ingredient, prostaglandin 1 2 analogues of the present invention have potent platelet aggregation inhibiting effect, blood pressure depressing effect, vasodilative effect and antiulcer effect, and are also low in toxicity.
    • 本发明公开了含有前列腺素I2,由下述通式表示的类似物或其盐的无毒性盐或其环糊精包合物作为有效成分的循环改善效果和抗溃疡作用的药物:其中R 1 >表示氢原子,碳原子数1〜12的烷基,碳原子数4〜7的环烷基或苯基,A表示戊基,环戊基,环己基,1-甲基-3 己炔基,2-甲基-3-己炔基,1-甲基己基,2-苯乙基,1,1-二甲基戊基,2-甲基戊基,1-环己基乙基,2-甲基己基 基团,2,6-二甲基-5-庚烯基上的1-甲基-3-戊炔基,4-和5-位的碳原子之间的双键是E或Z或其混合物,不对称中心 在由A表示的取代基中是R构型或S-构型或其混合物。 含有本发明的前列腺素I2类似物作为活性成分的药物具有有效的血小板聚集抑制作用,降血压作用,血管扩张作用和抗溃疡作用,毒性也低。